A detailed history of Tekla Capital Management LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Tekla Capital Management LLC holds 41,465 shares of UTHR stock, worth $13.2 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
41,465
Previous 61,200 32.25%
Holding current value
$13.2 Million
Previous $13.7 Million 33.22%
% of portfolio
0.36%
Previous 0.53%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$205.19 - $232.99 $4.05 Million - $4.6 Million
-19,735 Reduced 32.25%
41,465 $9.15 Million
Q1 2023

May 10, 2023

SELL
$212.99 - $276.17 $11.5 Million - $14.9 Million
-53,877 Reduced 46.82%
61,200 $13.7 Million
Q4 2022

Feb 10, 2023

SELL
$205.95 - $280.43 $473,685 - $644,989
-2,300 Reduced 1.96%
115,077 $32 Million
Q3 2022

Nov 01, 2022

BUY
$203.3 - $244.17 $9.18 Million - $11 Million
45,171 Added 62.56%
117,377 $24.6 Million
Q1 2022

May 13, 2022

SELL
$166.16 - $213.96 $4.91 Million - $6.32 Million
-29,531 Reduced 29.03%
72,206 $13 Million
Q4 2021

Feb 14, 2022

SELL
$184.32 - $216.08 $7.96 Million - $9.34 Million
-43,203 Reduced 29.81%
101,737 $22 Million
Q3 2021

Nov 12, 2021

BUY
$179.86 - $214.88 $989,589 - $1.18 Million
5,502 Added 3.95%
144,940 $26.8 Million
Q2 2021

Aug 13, 2021

BUY
$170.47 - $211.93 $12.9 Million - $16.1 Million
75,925 Added 119.54%
139,438 $25 Million
Q1 2020

May 14, 2020

BUY
$79.39 - $115.35 $747,774 - $1.09 Million
9,419 Added 17.41%
63,513 $6.02 Million
Q2 2019

Aug 14, 2019

BUY
$76.06 - $120.81 $976,077 - $1.55 Million
12,833 Added 31.1%
54,094 $4.22 Million
Q1 2018

May 14, 2018

BUY
$107.21 - $151.94 $2.68 Million - $3.8 Million
25,041 Added 154.38%
41,261 $4.64 Million
Q4 2017

Feb 14, 2018

SELL
$118.58 - $151.28 $3.29 Million - $4.2 Million
-27,741 Reduced 63.1%
16,220 $2.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
43,961
43,961 $5.7 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.